Literature DB >> 17086906

The Face-Symbol Test and the Symbol-Digit Test are not reliable surrogates for the Paced Auditory Serial Addition Test in multiple sclerosis.

J Williams1, K O'Rourke, M Hutchinson, N Tubridy.   

Abstract

The Paced Auditory Serial Addition Test (PASAT) is the chosen task for cognitive assessment in the multiple sclerosis functional composite (MSFC) and a widely used task in neuropsychological studies of people with multiple sclerosis (MS), but is unpopular with patients. The Face-Symbol Test (FST) and Symbol-Digit Tests (SDT) are alternative methods of cognitive testing in MS, which are easily administered and patient-friendly. In order to evaluate the potential of the FST as a possible surrogate for the PASAT, we directly compared the FST to the PASAT and the SDT in a cohort of 50 MS patients with varying levels of disability. There was significant correlation between SDT and FST scores (Spearman's rho 0.80, 95% CI 0.66-0.88), R(2) 65%, with moderate inter-test agreement (k =0.52). In contrast, SDT and FST scores were less predictive of PASAT scores. We concluded that neither the FST nor SDT are reliable surrogates for the PASAT.

Entities:  

Mesh:

Year:  2006        PMID: 17086906     DOI: 10.1177/1352458506070752

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  4 in total

1.  Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis.

Authors:  Amy T Waldman; Salim Chahin; Amy M Lavery; Geraldine Liu; Brenda L Banwell; Grant T Liu; Laura J Balcer
Journal:  Mult Scler Relat Disord       Date:  2016-08-26       Impact factor: 4.339

2.  Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis.

Authors:  Sebastian Horowski; Uwe K Zettl; Reiner Benecke; Uwe Walter
Journal:  J Neurol       Date:  2010-08-26       Impact factor: 4.849

3.  Evaluating sub-clinical cognitive dysfunction and event-related potentials (P300) in clinically isolated syndrome.

Authors:  Belgin Kocer; Tugba Unal; Bijen Nazliel; Zeynep Biyikli; Zulal Yesilbudak; Sirel Karakas; Ceyla Irkec
Journal:  Neurol Sci       Date:  2008-11-11       Impact factor: 3.307

4.  Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.

Authors:  Katrin Weier; Iris K Penner; Stefano Magon; Michael Amann; Yvonne Naegelin; Michaela Andelova; Tobias Derfuss; Christoph Stippich; Ernst-Wilhelm Radue; Ludwig Kappos; Till Sprenger
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.